prostate-report.org

Aspirin may lower PSA levels levels among men with prostate cancer.

Researchers at Vanderbilt University have found that the use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower PSA (prostate-specific antigen) levels, especially among men with prostate cancer.

After taking into account age, race, family prostate cancer history, obesity, and other variables that have independent effects on the size of the prostate organ, cancer risk, and PSA levels, the researchers found that aspirin use was significantly associated with lower PSA levels.

The study will be presented at the American Association for Cancer Research’s Seventh Annual International Conference on Frontiers in Cancer Prevention Research.